High Falls Advisors’s Medtronic MDT Stock Holding History

High Falls Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,854	Closed	-$206K	–	116
2022 Q1	$206K	Buy	+1,854	New	+$196K	0.06%	114
2021 Q4	–	Sell	-1,854	Closed	-$232K	–	134
2021 Q3	$232K	Sell	1,854 -161	-8%	-$20.8K	0.06%	112
2021 Q2	$250K	Hold	2,015	–	–	0.07%	110
2021 Q1	$238K	Sell	2,015 -93	-4%	-$10.9K	0.07%	104
2020 Q4	$247K	Buy	+2,108	New	+$232K	0.07%	95
2020 Q1	–	Sell	-1,909	Closed	-$217K	–	94
2019 Q4	$217K	Hold	1,909	–	–	0.06%	91
2019 Q3	$207K	Buy	+1,909	New	+$199K	0.06%	91

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

High Falls Advisors's MDT Position: Q2 2022 in Review

High Falls Advisors sold out of Medtronic (MDT) in Q2 2022, closing a stake of 1,854 shares — an estimated $206K sold.

High Falls Advisors first reported a position in MDT in Q3 2019 and held it in 7 quarters. The position peaked at $250K in Q2 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

High Falls Advisors reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
High Falls Advisors sold 1,854 Medtronic shares in Q2 2022, an estimated $206K.
High Falls Advisors first reported a position in Medtronic in Q3 2019 and held it in 7 quarters.
High Falls Advisors's Medtronic position peaked at $250K in Q2 2021.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on High Falls Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.